Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Risk Factors and Prognostic Scoring Model for 28-Day Mortality in Hematologic Patients with Stenotrophomonas M altophilia B acteremia

Wenjing Guo, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7430.

https://doi.org/10.1182/blood-2023-185820

Published: 2023

Journal Articles

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2023-188534

Published: 2023

Journal Articles

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Xiaoyu Zhang, Shulian Chen, Weihua Zhai, Yi He, Sizhou Feng, Mingzhe Han, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zepin Zhou, Fang Zhou, Rui Xi, Li Liu, Wei Yang, Xi Zhang, Qifa Liu, Erlie Jiang

Blood (2023) 142 (Supplement 1): 474.

https://doi.org/10.1182/blood-2023-184477

Published: 2023

Journal Articles

Recipient Resident Macrophage Plays a Crucial Role in Acute Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation By Regulation of Damage-Associated Molecular Pattern Phagocytosis

Yuyan Shen, Tingting Zhang, Zhangjie Chen, Sisi Zhen, Jieru Wang, Erlie Jiang, Xudong Liao, Sizhou Feng

Blood (2023) 142 (Supplement 1): 4798.

https://doi.org/10.1182/blood-2023-185874

Published: 2023

Journal Articles

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Xiaoyu Zhang, Donglin Yang, Aiming Pang, Yi He, Jialin Wei, Rongli Zhang, Weihua Zhai, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2023-182816

Published: 2023

Journal Articles

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in Patients with Hematologic Diseases: A Single-Center Retrospective Study

Jieru Wang, Sisi Zhen, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 2163.

https://doi.org/10.1182/blood-2023-189152

Published: 2023

Journal Articles

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Runzhi Ma, Sisi Zhen, Li Liu, Jieru Wang, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7094.

https://doi.org/10.1182/blood-2023-190923

Published: 2023

Journal Articles

Is Short-Course Antibiotic Therapy Suitable for Pseudomonas Aeruginosa Bloodstream Infections in Onco-Hematology Patients with Febrile Neutropenia? Results of a Multi-Institutional Analysis

Xiaomeng Feng, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5919.

https://doi.org/10.1182/blood-2023-188177

Published: 2023

Journal Articles

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2023-181449

Published: 2023

Journal Articles

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Sisi Zhen, Qingsong Lin, Weihua Zhai, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2023-188815

Published: 2023

Journal Articles

MAIT Cell Proliferation Is a Potential Early Diagnosis Marker for Blood Stream Infection in AML Patients

Sizhou Feng, Yuping Fan, Sudong Zhang, Xiaomeng Feng, Yuanfu Xu, Erlie Jiang

Blood (2023) 142 (Supplement 1): 2558.

https://doi.org/10.1182/blood-2023-189275

Published: 2023

Journal Articles

Diagnostic Performance and Clinical Impacts of Metagenomic Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

Chunhui Xu, Xin Chen, Huiming Yi, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5020.

https://doi.org/10.1182/blood-2023-187950

Published: 2023

Journal Articles

Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification

Chen Liang, Aiming Pang, Yi He, Donglin Yang, Rongli Zhang, Qiaoling MA, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 3619.

https://doi.org/10.1182/blood-2023-184582

Published: 2023

Journal Articles

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5892.

https://doi.org/10.1182/blood-2023-184400

Published: 2023

Journal Articles

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Yanhong Zhao, Weihua Zhai, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5893.

https://doi.org/10.1182/blood-2023-184565

Published: 2023

Journal Articles

Recombinant Human Thrombopoietin Reduces the Risk of Acute Graft-Versus-Host-Disease and Its Mechanisms

Fei Rong, Chunting Zhao, Xiaodan Liu, Xiaolin Ma, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 6962.

https://doi.org/10.1182/blood-2023-188903

Published: 2023

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

Epidemiological Characteristics and Drug-Resistance Genotype of CRE in Patients with Hematological Diseases in a Single Center of China

Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5841.

https://doi.org/10.1182/blood-2023-188528

Published: 2023

Journal Articles

Haematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anaemia: Clinical Characteristics, Outcomes and Risk Factors

Li Jia, Yilin Liu, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7105.

https://doi.org/10.1182/blood-2023-188427

Published: 2023

Journal Articles

Evaluation of Platelet and Clotting Parameters in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Patients with Candidemia

Hongchen Bi, Xiaoli Luo, Haozhi Zhang, Mingyang Wang, Aiming Pang, Sizhou Feng, Erlie Jiang, Yujie Cui

Blood (2023) 142 (Supplement 1): 5441.

https://doi.org/10.1182/blood-2023-188010

Published: 2023

NARROW

Risk Factors and Prognostic Scoring Model for 28-Day Mortality in Hematologic Patients with Stenotrophomonas M altophilia B acteremia

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Recipient Resident Macrophage Plays a Crucial Role in Acute Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation By Regulation of Damage-Associated Molecular Pattern Phagocytosis

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in Patients with Hematologic Diseases: A Single-Center Retrospective Study

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Is Short-Course Antibiotic Therapy Suitable for Pseudomonas Aeruginosa Bloodstream Infections in Onco-Hematology Patients with Febrile Neutropenia? Results of a Multi-Institutional Analysis

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

MAIT Cell Proliferation Is a Potential Early Diagnosis Marker for Blood Stream Infection in AML Patients

Diagnostic Performance and Clinical Impacts of Metagenomic Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Recombinant Human Thrombopoietin Reduces the Risk of Acute Graft-Versus-Host-Disease and Its Mechanisms

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Epidemiological Characteristics and Drug-Resistance Genotype of CRE in Patients with Hematological Diseases in a Single Center of China

Haematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anaemia: Clinical Characteristics, Outcomes and Risk Factors

Evaluation of Platelet and Clotting Parameters in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Patients with Candidemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only